News & Updates

Show Multimedia Only

Statins, triple antihypertensive combination may lower ICH recurrence risk

31 May 2023 by

Statin therapy, as well as triple antihypertensive combination therapy, may reduce the risk of recurrence in patients who have survived an intracerebral haemorrhage (ICH), according to new local findings presented at HKMF 2023.

31 May 2023

Nitrate supplements may lower risk of diabetes complications, mortality in hyperglycaemic adults

30 May 2023 by

Increased levels of urinary nitrate appear to contribute to a reduction in the risk of congestive heart failure and diabetic retinopathy and may also lower the risk of death from all causes, cardiovascular disease (CVD), and diabetes in adults with hyperglycaemia, suggests a study.

30 May 2023

Falls a red flag for poor outcomes in atrial fibrillation

29 May 2023

Fall episodes in individuals with atrial fibrillation (AF) may signal poor outcomes, including intracranial haemorrhage and mortality, according to a study.

29 May 2023

Cognitive protection greater with intensive vs standard SBP lowering for high-risk individuals

29 May 2023

For individuals with increased projected risk of probable dementia or amnestic mild cognitive impairment (MCI) who are prescribed antihypertensive treatment, intensive systolic blood pressure (SBP) lowering confers greater cognitive benefits than standard treatment, according to a secondary analysis of the SPRINT trial.

29 May 2023

Clevidipine trumps nicardipine for BP control in patients undergoing cardiac surgery

28 May 2023

Treatment with clevidipine in patients undergoing cardiac surgery leads to better perioperative blood pressure (BP) control relative to nicardipine, with a slight rise in cost and no significant difference in safety outcomes, a study has found.

28 May 2023

GLP1RA added to antidiabetic drugs prevents MACE, HF hospitalization

28 May 2023

Adding glucagon-like peptide-1 receptor agonists (GLP1RA) onto metformin, sulfonylurea, or insulin treatment alone or in combination appears to reduce the incidence of major adverse cardiac events (MACE) and heart failure (HF) hospitalization relative to treatment with dipeptidyl peptidase-4 inhibitors (DPP4i), suggests a study.

28 May 2023

Amiodarone plus apixaban/rivaroxaban ups bleeding-related hospitalizations in older AF patients

27 May 2023

Use of amiodarone in older patients with atrial fibrillation (AF) who are being treated with apixaban or rivaroxaban results in a higher risk of bleeding-related hospitalizations compared with the use of flecainide or sotalol, reports a study.

27 May 2023